IBIMA-BIONAND Platform
If you are the contact person for this centre and you wish to make any changes, please contact us.
Senior researcher and group leader at CIBER for Diabetes and Associated Metabolic Diseases (CIBERDEM), researcher at the Regional University Hospital of Malaga and at IBIMA-Bionand platform
Full professor of Preventive Medicine and Public Health at the University of Malaga, researcher in charge of the A-23 Preventive Medicine and Public Health research group of IBIMA-BINOAND Platform
In an analysis published by The Lancet Global Health, a panel of specialists urges the medical community to recognize type 5 diabetes as a disease distinct from other types of diabetes. This form of the disease —first described in 1955 and whose name “type 5” was recognized by the International Diabetes Federation in April 2025— affects 25 million people with a low body mass index, mainly in low- and middle-income countries, according to the authors' estimates. People with type 5 diabetes do not produce enough insulin, but their bodies process insulin normally. In addition, they do not usually suffer from ketoacidosis —an acute metabolic complication of diabetes— and their immune systems do not attack the pancreas.
A study published today in Science Advances suggests that there may be a correlation between having a high body mass index (BMI) in childhood and developing schizophrenia later in life. However, the study also indicates that having a higher BMI in adulthood may be correlated with a lower risk of schizophrenia and obsessive-compulsive disorder.